Sai Parenterals Limited has informed the Exchange about Shareholders meeting
Sai Parenterals' Australian unit, Noumed, renewed a 3-year supply agreement valued at AUD 30 million (approx. INR 204 Cr). This expands the group's total Australian OTC contracted supply to AUD 232 million.
Sai Parenterals' subsidiary has renewed a 3-year OTC Medicines Supply Agreement with a leading Australian pharmacy chain. The deal is valued at AUD 30 million, approx Rs. 204 Cr.
Sai Parenterals Limited management will participate in a group meeting with Analysts/Institutional Investors in Mumbai. Discussions will be limited to publicly available information.
Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.
